U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07594665) titled 'Expanding Access to Cognitive Health Biomarker Testing at Home' on May 11.
Brief Summary: The goal of this observational study is to learn whether at-home blood biomarker testing for Alzheimer's disease risk is feasible and acceptable in older adults with cognitive concerns. The main questions it aims to answer are:
* Can older adults with subjective cognitive concerns or possible mild cognitive impairment successfully complete a fully remote workflow that includes at-home capillary blood collection, overnight shipping, central laboratory analysis of phosphorylated tau-217 (p-tau217), and remote disclosure of results by a neurologis...